Consumer Driven Health Care

Although Gov. Ron DeSantis signed the plan into law in 2019, it required federal review and approval by the FDA.

Industry leaders share their thoughts, comments, and concerns about diversity, equity, and inclusion in today's workforce and how it will affect their 2024.

Cancer patients received letters from the prestigious Manhattan hospital in December claiming the insurer would soon drop their coverage, but there is now a tentative agreement in place to provide coverage through April 14.

The FDA has authorized roughly two dozen AI products to help diagnose cancer from mammograms, which are being rolled out in different states. However, patients must pay an extra fee – often $40 – for the AI analysis.

A group of 19 senators sent a letter to the U.S. Department of Health and Human Services to rethink its appeal of a recent court decision permitting the use of copay accumulator programs that help patients pay for their drugs.

The pharmaceutical giant has launched a telehealth-connected website to allow patients to directly order the weight loss drug, as well as insulin products and a migraine drug, direct from the company.

Michigan's top insurance regulator told health plans on Monday that they cannot deny coverage for clinically proven cancer treatments, after a deceased patient's insurer refused to pay for life-saving gene therapy treatment.

Federal regulations require health insurers to promptly hand over records to patients facing claim denials within 30 days, however, Anthem, Aetna and UnitedHealth blew past the 30-day deadline in a recent ProPublica investigation.